Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person

I am a payer or formulary decision-maker

I am neither (take me to AstraZeneca.com)

Chronic Obstructive Pulmonary Disease

Scientific Resources

This section offers scientific resources related to COPD, including videos, slide decks, and infographics. Our AstraZeneca Medical team has created this content as an information service for healthcare professionals. Updates are made as new content becomes available. This section also includes links to resources provided by The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and The COPD Foundation.

Videos

An animated exploration of the PRIMUS Study

This video is a brief overview of the PRIMUS study in a whiteboard-style animation

Navigating inhaler choice and training video

This video discusses navigating the complexities of inhaler choice and training

Physical activity roundtable video

This video discusses reduced activity in patients with COPD and the impact on COPD outcomes, stimulating patient engagement to improve management of COPD, and practical approaches to increasing physical activity

Slide Decks

This presentation provides an overview of the analysis of triple therapy initiation following a disease exacerbation among patients with chronic obstructive pulmonary disease (PRIMUS)

This presentation reviews the pathophysiology of COPD and the updated GOLD 2024 Report

This presentation reviews the importance of inhaler device selection, types of devices available, and the importance of training

Infographics

2-page infographic illustrates the evolution of race-based spirometry and its implications for COPD diagnosis across diverse patient populations

Transition of Care Discharge Checklist for patients with COPD discharged after COPD hospitalization

This content includes the Global Initiative for Chronic Obstructive Lung Disease (GOLD) report figures for the ABE Assessment Tool, Initial Pharmacological Treatment, Follow-up Pharmacological Treatment, and Factors to Consider when Adding ICS to Long-Acting Bronchodilators

External Resources

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with healthcare professionals and public health officials around the world to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease.

The COPD Foundation is a patient-centred organization committed to preventing COPD, bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease, and to seeking cures while improving lives and advocating for all affected.

AvoMD is a software platform that translates clinical evidence, including the GOLD 2024 Report, into the workflow at the point of care, and is available in the electronic health record or as a standalone web/mobile application.

US-87032 Last Updated 6/24

Welcome to AstraZeneca Medical Information

Welcome to AstraZeneca
Medical Information